Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1622
    -0.0061 (-0.52%)
     
  • GBP/USD

    1.2384
    -0.0054 (-0.43%)
     
  • Bitcoin GBP

    51,886.26
    +727.24 (+1.42%)
     
  • CMC Crypto 200

    1,378.55
    +65.93 (+5.02%)
     
  • S&P 500

    4,984.06
    -27.06 (-0.54%)
     
  • DOW

    37,988.11
    +212.73 (+0.56%)
     
  • CRUDE OIL

    83.55
    +0.82 (+0.99%)
     
  • GOLD FUTURES

    2,415.00
    +17.00 (+0.71%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

South Africa's Sibanye Gold says no intention to bid for Acacia assets

(Adds Sibanye statement, Acacia share movement)

WESTONARIA, South Africa, July 28 (Reuters) - South Africa's Sibanye Gold does not intend to make make an offer for the assets of Barrick Gold (Hanover: ABR.HA - news) 's African unit Acacia Mining (LSE: ABG.L - news) , it said on Thursday.

Hours after its chief executive told Reuters that Sibanye might have been interested, the company said in a brief statement: "Sibanye confirms that it was considering a possible offer for Acacia, but confirms it is no longer actively considering an offer."

Barrick Gold, the world's largest gold producer, is weighing a sale of its majority stake in Acacia and has approached several South African miners, sources familiar with the situation told Reuters this week.

ADVERTISEMENT

Barrick owns 64 percent of Acacia, a London-listed miner with three producing gold mines in Tanzania: Bulyanhulu, Buzwagi and North Mara. Much of the remainder of Acacia is widely held.

Acacia also has exploration projects in Tanzania and other parts of Africa.

Shares (Berlin: DI6.BE - news) in Acacia were up 5 percent at 602.5 pence at 1049 GMT on the London Stock Exchange (Other OTC: LDNXF - news) . (Reporting by Ed Stoddard and Esha Vaish; Writing by Joe Brock; Editing by James Macharia/Ruth Pitchford)